These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30809807)

  • 1. Valproic acid and Stevens-Johnson syndrome: a systematic review of descriptive studies.
    Rashid M; Kashyap A; Undela K
    Int J Dermatol; 2019 Sep; 58(9):1014-1022. PubMed ID: 30809807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine-induced severe cutaneous adverse reactions.
    Schlienger RG; Shapiro LE; Shear NH
    Epilepsia; 1998; 39 Suppl 7():S22-6. PubMed ID: 9798758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid.
    Yalçin B; Karaduman A
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):898-9. PubMed ID: 11044815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
    Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
    Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
    Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
    Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine-induced severe cutaneous adverse reaction: Update data from 1999-2014.
    Wang XQ; Lv B; Wang HF; Zhang X; Yu SY; Huang XS; Zhang JT; Tian CL; Lang SY
    J Clin Neurosci; 2015 Jun; 22(6):1005-11. PubMed ID: 25913750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid.
    Kocak S; Girisgin SA; Gul M; Cander B; Kaya H; Kaya E
    Am J Clin Dermatol; 2007; 8(2):107-11. PubMed ID: 17428116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens - Johnson Syndrome Induced by Combination of Lamotrigine and Valproic Acid in a 9-Year-Old Boy.
    Maduemem K; Vatca A; O'Neill T; Buckley D
    Ir Med J; 2017 Jun; 110(6):586. PubMed ID: 28952676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
    Kaufman KR; Gerner R
    Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions induced by valproic acid.
    Nanau RM; Neuman MG
    Clin Biochem; 2013 Oct; 46(15):1323-38. PubMed ID: 23792104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
    Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R
    Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dosage in new users of lamotrigine inducing epidermal necrolysis: Results of the German Registry of Severe Skin Reactions.
    Diederich S; Hemmeter U; Paulmann M; Mockenhaupt M
    Epilepsia; 2023 May; 64(5):1259-1265. PubMed ID: 36855234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.
    Ordoñez L; Salgueiro E; Jimeno FJ; Manso G
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2732-7. PubMed ID: 26221907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
    Syu FK; Pan HY; Chuang PC; Huang YS; Cheng CY; Cheng FJ
    J Dermatol; 2018 Sep; 45(9):1080-1087. PubMed ID: 29963717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population.
    Patel TK; Barvaliya MJ; Sharma D; Tripathi C
    Indian J Dermatol Venereol Leprol; 2013; 79(3):389-98. PubMed ID: 23619444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X; Liu W; Zhou W
    J Clin Pharm Ther; 2018 Jun; 43(3):408-413. PubMed ID: 29274302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine and toxic epidermal necrolysis.
    Vukelíc D; Bozinović D; Tesović G; Dobrić I; Loncarić D; Knezović I; Skerlev M
    Dermatology; 1997; 195(3):307. PubMed ID: 9407193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.